Clinical Trials Directory

Trials / Unknown

UnknownNCT04473846

Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures.

The Use of Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures: a Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Jordan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Conscious sedation provides adequate control of pain and anxiety for the majority of routine endoscopic procedures as well as adequate amnesia. Sedation practices vary widely, with some colonoscopists advocating sedation only for the most difficult cases of colonoscopy, while others prefer using deep sedation or general anaesthesia for colonoscopy. However, many physicians are still using moderate sedation for the majority of patients. The use of propofol, a short acting anesthetic agent, for conscious sedation provides a considerably more rapid onset of action and shorter recovery time, for which it is believed to be a safe drug of choice for patients undergoing endoscopic procedures. Although propofol cannot be used as a single agent for moderate sedation, it can be effectively titrated to moderate sedation after administration of small doses of narcotics and sedatives. The aim of this study is to compare between general anesthesia and deep sedation using propofol-fentanyl-ketamine (PFK) preparation in terms of perioperative vital signs, intraoperative awareness, post-operative pain scores, and the use of analgesia postoperatively.

Conditions

Interventions

TypeNameDescription
DRUGPK general anesthesiaPatients will be anesthetized using Fentanyl (2 mcg/kg) and Propofol (1-2 mg/kg).
DRUGPFK combinationEach patient received an initial dose of 0.05 ml/kg from the solution, then after waiting for 60 seconds, another 0.05 ml/kg were given. Maintenance was given as boluses of 0.025 ml/kg every three to five minutes.

Timeline

Start date
2020-08-01
Primary completion
2020-12-01
Completion
2021-06-01
First posted
2020-07-16
Last updated
2020-07-16

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04473846. Inclusion in this directory is not an endorsement.